News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History
December, 2023
December 2023
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Justin J. Friedly: I believe there is still a tremendous opportunity to seek and lead the convergence of diagnostics, therapeutics, and data
Photo taken from Justin J. Friedly/LinkedIn
Oct 15, 2023, 16:06

Justin J. Friedly: I believe there is still a tremendous opportunity to seek and lead the convergence of diagnostics, therapeutics, and data

Justin J. Friedly, Former Vice President of National Accounts at Caris Life Sciences, shared on LinkedIn:

“Over the last 18+ years of my career, I have witnessed a radical transformation in oncology diagnostics. The early years included the automation of immunohistochemistry, which is now the standard of practice in anatomic pathology labs. (Thank you, Dr. Grogan) Healthcare has now begun the transition to the power of genomics and the market is tasked to drive testing closer to the patient to improve care and outcomes. While this progress has had huge impacts on the lives of those afflicted with cancer – I believe there is still a tremendous opportunity to seek and lead the convergence of diagnostics, therapeutics, and data.

I am thrilled with the number of organizational executive leaders that have reached out to me over the last week to discuss how this can be achieved. Compartmentalization of efforts by discipline over the last decade has throttled the potential of these synergies. Organizations that seek to embrace a variety of professional experiences, knowledge, and relationships will truly drive the frontier of cancer care globally. The harmonization of diagnostics, therapeutics, data, and AI within the walls of a single organization will break every paradigm that currently exists.

I am excited to find my new ‘family’ that embraces this concept and culture, not out of fear or necessity, but out of what is ultimately best for the patient and the future of cancer care in the U.S. and Global Markets.

Hoping to be blessed with a new journey and opportunity soon…”

Source: Justin J. Friedly/LinkedIn

cancer Justin J. Friedly OncoDaily Oncology
Insight
Dec 9, 2023, 04:44
President Biden: It's good for the millions of Americans who can't afford their medications
Blog
Dec 9, 2023, 00:38
Thomas Hofmarcher: This is what a great panel discussion looks like!
Blog
Dec 9, 2023, 00:32
Zhiheng Xu: It's not just about how much statistics you know
Blog
Dec 9, 2023, 00:23
Priscilla Chan: Mark and I wrote our annual letter this year about how some of our earliest bets in science are letting us take advantage of this moment in AI
Blog
Dec 9, 2023, 00:18
David Fajgenbaum: 1 in 10 of us will develop a disease with no treatments
Career
Dec 8, 2023, 17:54
Dana-Farber News congratulates Sara Tolaney on receiving the Susan G. Komen 2023 Rising Star Researcher Award
Drugs
Dec 8, 2023, 17:50
Pure Biologics to test molecule PBA-0405 in project PB004 in a Phase 0 clinical trial in patients with solid tumors - The Antibody Society
Drugs
Dec 8, 2023, 17:46
Earle Burgess: Interested in new treatments being developed for advanced (urothelial) bladder cancer?
Insight
Dec 8, 2023, 17:40
Ibrahim Halil Sahin: A common question I received after my tweet on the PEGASUS trial...
Career
Dec 8, 2023, 17:35
Timothy M. Pawlik: Excited to announce Samilia Obeng-Gyasi as THE inaugural Endowed Surgical Professor in Health Equity
Insight
Dec 8, 2023, 17:32
Daniel Stover: Tumor genomic testing (TGT) is standard for MBC patients
Blog
Dec 8, 2023, 17:27
Tedros Adhanom Ghebreyesus: Gaza cannot afford to lose any more hospitals…
Insight
Positive
Societies
Career